Trial intelligence / Profile preview

Yahom Thepajit for treatment of depression

TCTR20240918005Phase 2Completed

Sponsor
Research and development office
Start
Nov 2018
Countries
1
01

Overview

Phase 2 trial in major depressive disorder (MDD), sponsored by Research and development office. Started Nov 2018; status: completed.

02

Conditions

major depressive disorder (MDD)

Beyond the preview

Go deeper on TCTR20240918005.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on TCTR20240918005.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call